A detailed history of Tower Trust & Investment CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Tower Trust & Investment CO holds 100 shares of LLY stock, worth $75,557. This represents 0.07% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$75,557
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$725.72 - $929.72 $72,572 - $92,972
100 New
100 $89.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $718B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tower Trust & Investment CO Portfolio

Follow Tower Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Tower Trust & Investment CO with notifications on news.